Grupo Espanol De Tumores Neuroendocrinos

This study tested two immunotherapy drugs, durvalumab and tremelimumab, in people with advanced thyroid cancer that had stopped responding to standard treatments. The goal was to see if the combination could slow or stop cancer growth. The trial was stopped early, and results wer…